Skip to main content
main-content
Top

22-11-2017 | Colorectal cancer | Article

A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients

Journal:
Supportive Care in Cancer

Authors: Gudrun Piringer, Michael Fridrik, Alfred Fridrik, Andreas Leiherer, August Zabernigg, Richard Greil, Wolfgang Eisterer, Jörg Tschmelitsch, Alois Lang, Sophie Frantal, Sonja Burgstaller, Michael Gnant, Josef Thaler, on behalf of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)

Publisher: Springer Berlin Heidelberg

Abstract

Despite advances in adjuvant chemotherapy, 20–30% of patients in stages II–III colorectal cancer will eventually relapse. Observational studies showed a reduction in relapse rate, colon cancer-specific mortality, and overall mortality by physical activity. Results from prospective randomized interventional studies to confirm these observational data are lacking. The aims of this prospective single-arm multicenter pilot study are to evaluate feasibility and safety of exercise training after adjuvant chemotherapy in colorectal cancer patients.
The training was performed three times per week for 1 year and was increased gradually in three phases until reaching 18 metabolic equivalent task hours per week.
Overall, 30 patients were included. The planned training intensity could be achieved in all three phases. Patients experienced a performance increase of median 35.5 watt, a weight-loss of a median of 3.0 kg, and a reduction in body fat content of median 1.0% during this exercise training. The analysis showed early study termination due to non-compliance in 10/30 patients (33.3%), disease progression in 4 patients (13.3%), and serious adverse events in 2 patients (6.7%). About half of patients (46.7%) completed the pilot study as planned. Biomarker analysis from 20 patients showed a non-significant reduction in insulin-like growth factor 1 (IGF-1), insulin-like growth factor 2 (IGF-2) and insulin-like growth factor binding protein 3 (IGF-BP3) levels, significant increases in adiponectin and leptin levels, and a non-significant increase in C-peptide levels.
Exercise training is feasible in patients with colorectal cancer after completion of adjuvant chemotherapy. The main problem encountered during the study was compliance. To improve compliance of exercise training, several measures were adapted for the upcoming prospective randomized ABCSG C08 Exercise II study.

Please log in to get access to this content

Related topics